SCHEMBL4699249

SCHEMBL4699249

CN1CCN(c2cccc3cc(S(=O)(=O)N4CCc5ccccc54)cnc23)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 9/20 0.60
HTR2A P28223 4/20 0.60
PKM P14618 4/20 0.56
JAK2 O60674 2/20 0.56
DRD3 P35462 4/20 0.55
HTR1A P08908 2/20 0.55
HTR7 P34969 2/20 0.55
DRD4 P21917 1/20 0.55
HTR2C P28335 1/20 0.55
ALDH1A1 P00352 2/20 0.54
MCOLN3 Q8TDD5 1/20 0.54
DRD2 P14416 3/20 0.53
TSHR P16473 2/20 0.51
MAPK1 P28482 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
PDE4A P27815 1/20 0.47
PDE4B Q07343 1/20 0.47
PDE4C Q08493 1/20 0.47
PDE4D Q08499 1/20 0.47
AKR1C3 P42330 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4700533 0.99 HTR6 (0.59) HTR6HTR2APKMJAK2DRD3
SCHEMBL5820238 0.89 PKM (0.53) HTR6HTR2APKMJAK2HTR1A
SCHEMBL4702019 0.88 HTR6 (0.67) HTR6HTR2APKMJAK2DRD3
Hydrochloric Acid SCHEMBL4697947 0.88 HTR6 (0.66) HTR6HTR2APKMJAK2DRD3
SCHEMBL4698210 0.85 PKM (0.48) HTR6HTR2APKMJAK2HTR1A
SCHEMBL4699554 0.84 PKM (0.69) PKMJAK2ALDH1A1MCOLN3TSHR
SCHEMBL5757786 0.82 LMNA (0.45) HTR6HTR2APKMJAK2HTR1A
SCHEMBL4699254 0.81 HTR6 (0.60) HTR6HTR2APKMJAK2DRD3
SCHEMBL2197288 0.81 HTR6 (0.80) HTR6HTR2ADRD3HTR1AHTR7
SCHEMBL15503471 0.81 HTR6 (0.80) HTR6HTR2ADRD3HTR1AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660483-B1 8-(1-PIPERAZINYL)-QUINOLINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS GLAXO GROUP LTD (GB) 2008-12-24 EP claimed
US-20080275040-A1 8-(1-Piperazinyl)-Quinoline Derivatives and Their Use in the Treatment of Cns Disorders GLAXO GROUP LIMITED (GB) 2008-11-06 US claimed
EP-1660483-A1 8-(1-PIPERAZINYL)-QUINOLINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS GLAXO GROUP LIMITED (GB) 2006-05-31 EP claimed
WO-2005021530-A1 8- (1-PIPERAZINYL)- QUINOLINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS GLAXO GROUP LIMITED (GB) 2005-03-10 WO claimed
EP-1660483-B1 8-(1-PIPERAZINYL)-QUINOLINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS GLAXO GROUP LTD (GB) 2008-12-24 EP disclosed
US-20080275040-A1 8-(1-Piperazinyl)-Quinoline Derivatives and Their Use in the Treatment of Cns Disorders GLAXO GROUP LIMITED (GB) 2008-11-06 US disclosed
US-20080275040-A1 8-(1-Piperazinyl)-Quinoline Derivatives and Their Use in the Treatment of Cns Disorders GLAXO GROUP LIMITED (GB) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275040-A1 8-(1-Piperazinyl)-Quinoline Derivatives and Their Use in the Treatment of Cns Disorders PMP22, AQP4, SLC18A2 HTR6 139/4885HTR2A 82/4885PKM 1968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.